Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: Initial experience

Radiology

Volumn 242, Issue 1, 2007, Pages 217-224

  Matuszewski, Lars ^a   Persigehl, Thorsten ^a   Wall, Alexander ^a   Meier, Norbert ^a   Bieker, Ralf ^a   Kooijman, Hendrik ^b   Tombach, Bernd ^a   Mesters, Rolf ^a   Berdel, Wolfgang E ^a   Heindel, Walter ^a   Bremer, Christoph ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CALCULATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DENSITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHO PLANAR IMAGING; FEMALE; HUMAN; INFORMED CONSENT; INSTITUTIONAL ETHICS; MALE; MICROVASCULATURE; MUSCLE RELAXATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PELVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST;

BONE MARROW NEOPLASMS; CONTRAST MEDIA; DRUG APPROVAL; FEMALE; FERRIC COMPOUNDS; HUMANS; IMAGE ENHANCEMENT; LEUKEMIA, MYELOCYTIC, ACUTE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33845634712     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2421051355     Document Type: Article

References (41)

1. Folkman J, Cole P, Zimmerman S. Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 1966;164:491-502.
2. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000;96:2240-2245.
3. Dankbar B, Padro T, Leo R, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 2000;95:2630-2636.
4. De Raeve HR, Vermeulen PB, Vanderkerken K, Harris AL, Van Marck E. Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance. Virchows Arch 2004;445:27-33.
5. Kini AR, Kay NE, Peterson LC. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 2000;14:1414-1418.
6. Mesters RM, Padro T, Steins M, et al. Angiogenesis in patients with hematologic malignancies [in German]. Onkologie 2001;24(suppl 5):75-80.
7. Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000;95:2637-2644.
8. Kuzu I, Beksac M, Arat M, Celchi H, Elhan AH, Erekul S. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival. Leuk Lymphoma 2004;45:1185-1190.
9. Mesters RM, Padro T, Bieker R, et al. Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. Blood 2001;98:241-243.
10. Rabitsch W, Sperr WR, Lechner K, et al. Bone marrow microvessel density and its prognostic significance in AML. Leuk Lymphoma 2004;45:1369-1373.
11. Folkman J. Endothelial cells and angiogenic growth factors in cancer growth and metastasis; introduction. Cancer Metastasis Rev 1990;9:171-174.
12. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988;48:2641-2658.
13. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639-649.
14. Buckley DL, Drew PJ, Mussurakis S, Monson JR, Horsman A. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRT. J Magn Reson Imaging 1997;7:461-464.
15. Demsar F, Roberts TP, Schwickert HC, et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37:236-242.
16. Frouge C, Guinebretiere JM, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994;29:1043-1049.
17. Griebel J, Mayr NA, de Vries A, et al. Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging 1997;7:111-119.
18. Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res 1998;58:3598-3602.
19. Hawighorst H, Knapstein PG, Knopp MV, et al. Angiogeriesis of cervix carcinoma: contrast enhanced dynamic MRI, histologic quantification of capillary density and lymphatic system infiltration [in German]. Radiologe 1998;38:50-57.
20. Hawighorst H, Schaeffer U, Knapstein PG, et al. Detection of angiogenesis-dependent parameters by functional MRI: correlation with histomorphology and evaluation of clinical relevance as prognostic factor using cervix carcinoma as an example. Rofo 1998;169:499-504.
21. Roberts HC, Saeed M, Roberts TP, et al. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability. J Magn Reson Imaging 1997;7:331-338.
22. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
23. Bremer C, Mustafa M, Bogdanov A Jr, Ntziachristos V, Petrovsky A, Weissleder R. Steady-state blood volume measurements in experimental tumors with different angiogenic burdens: a study in mice. Radiology 2003;226:214-220.
24. Padro T, Bieker R, Ruiz S, et al. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 2002;16:1302-1310.
25. Allkemper T, Bremer C, Matuszewski L, Ebert W, Reimer P. Contrast-enhanced blood-pool MR angiography with optimized iron oxides; effect of size ancl dose on vascular contrast enhancement in rabbits. Radiology 2002;223:432-438.
26. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793-799.
27. Zhu H, Melder RJ, Baxter LT, Jain RK. Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy. Cancer Res 1996;56:3771-3781.
28. Renger BC, Schuierer G, Meier N, et al. Perfusion, diffusion and functional imaging parameter images with a single application. Amsterdam, the Netherlands: Elsevier, 1997.
29. Decaussin M, Sartelet H, Robert C, et al. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. J Pathol 1999;188:369-377.
30. Gobbi H, Dupont WD, Simpson JF, et al. Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst 1999;91:2096-2101.
31. Yuan A, Yu CJ, Chen WJ, et al. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 2000;89:475-483.
32. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000;34:148-135.
33. Lewin M, Bredow S, Sergeyev N, Marecos E, Bogdanov A Jr, Weissleder R. In vivo assessment of vascular endothelial growth factor-induced angiogenesis. Int J Cancer 1999;83:798-802.
34. Turetschek K, Huber S, Floyd E, et al. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001;218:562-569.
35. Bredow S, Lewin M, Hofmann B, Marecos E, Weissleder R. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. Eur J Cancer 2000;36:675-681.
36. Rahmouni A, Montazel JL, Divine M, et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology 2003;229:710-717.
37. Montazel JL, Divine M, Lepage E, Kobeiter H, Breil S, Rahmouni A. Normal spinal bone marrow in adults: dynamic gadolinium-enhanced MR imaging. Radiology 2003;229:703-709.
38. Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 2002;12:1557-1566.
39. Tombach B, Reimer P, Bremer C, et al. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. NMR Biomed 2004;17:500-506.
40. Dahnke H, Bachmann R, Heindel W, Bremer C, Schaefter T. Fast T2* mapping with SENSE acquisition and field inhomogeneity correction for lesion characterization and sensitive SPIO detection at 3.0 T [abstract]. In: Proceedings of the 13th Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2005; 432.
41. Dahnke H, Persigehl T, Wall A, Heindel W, Bremer C, Schaeffter T. Optimal calculation of MR-relaxation rate changes for quantitative tumor blood volume determination at 3.0 T [abstract]. In: Proceedings of the 13th Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2005; 13.